Clinical trials
Stroke trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
154 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 5 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 9 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 10 |
| 2014 | 9 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 9 |
| 2019 | 13 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 9 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 84 |
| Recruiting | 22 |
| Unknown status | 18 |
| Terminated | 15 |
| Active, not recruiting | 9 |
| Not yet recruiting | 4 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 21 |
| Danderyd Hospital | 12 |
| Göteborg University | 9 |
| Region Skane | 9 |
| Umeå University | 9 |
| Boehringer Ingelheim | 6 |
| Bayer | 5 |
| AstraZeneca | 4 |
| Novartis Pharmaceuticals | 4 |
| Vastra Gotaland Region | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 154 |
| Atrial Fibrillation | 25 |
| Ischemic Stroke | 21 |
| Myocardial Infarction | 14 |
| Cardiovascular Diseases | 13 |
| Paresis | 9 |
| Ischemic Attack, Transient | 8 |
| Brain Injuries, Traumatic | 7 |
| Aphasia | 5 |
| Cerebral Hemorrhage | 5 |
Trials
Showing 1 to 25 of 154. Each trial links to its page on Pharma Observatory.
54 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.